baber/WOPTO huggingface dataset:
Patent JP-4079991-B2 (JP)
IPC: C07C51/41
Filed: 1994-04-19
Granted: 2008-04-23
Abstract: PCT No. PCT/EP94/01202 Sec. 371 Date Nov. 24, 1995 Sec. 102(e) Date Nov. 24, 1995 PCT Filed Apr. 19, 1994 PCT Pub. No. WO94/25422 PCT Pub. Date Nov. 10, 1994This invention relates to the preparation of cesium salts from cesium-aluminum-alum in a process in which the cesium-aluminum-alum is reacted in a single vessel in the presence of water with calcium hydroxide in an amount which is equimolar to the amount of aluminum and with a readily water-soluble calcium salt in an amount which is equimolar to the amount of cesium and the precipitated aluminum hydroxide and the precipitated calcium sulfate are separated by filtration or centrifugation.
Patent JP-3830167-B2 (JP)
IPC: G01N15/02
Filed: 1997-11-26
Granted: 2006-10-04
Abstract: PCT No. PCT/EP97/06601 Sec. 371 Date Aug. 11, 1999 Sec. 102(e) Date Aug. 11, 1999 PCT Filed Nov. 26, 1997 PCT Pub. No. WO98/23941 PCT Pub. Date Jun. 4, 1998A method and device are disclosed for expanding the field of application of florescent correlation spectroscopy. The device has a confocal optical structure, a pulsed laser for excitation and components for detection and evaluation of measuring signals for time-correlated single photon counting. The data is registered in such a way that for each detected photon, detection time is recorded in microseconds while fluorescence delay time is recorded in nanoseconds. The information on each detected photon is used to assign parameters determined by time-correlated single photon counting to each detected photon and to create correlation functions from the determined parameters arising therefrom. Correlation functions of parameters or selective correlation functions, e.g. for fluorescence burning life, are thus obtained. The method and the device can also be used to detect individual molecules and to calculate correlation functions only for those signal segments which are assigned to the individually existing particles, thereby improving the signal-to-noise ratio in extremely diluted solutions.
Patent ES-2548631-B2 (ES)
Title: Cable n-polar formado por n conductores unipolares desnudos y sus accesorios
Inventor: SAENZ-DIEZ MURO JUAN CARLOS
IPC: H01B17/00
Filed: 2015-05-21
Granted: 2016-02-25
Abstract: Cable n-polar formado por n conductores unipolares desnudos (1) y sus accesorios: grapa de suspensión (2), grapa de amarre (3) y terminal de exterior (4), del tipo de los que incorporan una pluralidad de conductores empleados para construir tendidos eléctricos, que fundamentalmente consta de: - n-conductores (11A, 11B, 11C) desnudos; - un aislamiento (13) de geometría cilíndrica dotado de n-alojamientos (12A, 12B, 12C), cuya función es mantener el aislamiento eléctrico entre los diferentes conductores (11A, 11B, 11C) ya que estos son desnudos y que dispone de una cubierta exterior (16) para protección exterior; - un alma resistente aislante (10) o conductora (10) cuya función es soportar la tensión mecánica de tracción necesaria para soportar tendido el cable (1); - una pluralidad de aletas aislantes rectas (14) y de aletas aislantes curvadas (15), siendo su función la de aumentar la línea de fuga y la protección de la avifauna.
Patent ES-2547468-B2 (ES)
Title: Método y sistema para la detección de faltas a tierra en sistemas de corriente continua alimentados mediante un rectificador
Inventor: BLANQUEZ DELGADO FRANCISCO
IPC: H02K19/38
Filed: 2015-04-28
Granted: 2017-03-16
Abstract: Método y sistema para la detección de faltas a tierra en sistemas de corriente continua alimentados mediante un rectificador.#La presente invención se refiere a un método y un sistema para la detección de faltas a tierra en sistemas de corriente continua alimentados mediante un rectificador y un transformador. La invención comprende: obtener una señal de tensión en una impedancia de puesta a tierra conectada al transformador; obtener una segunda señal de tensión entre uno de los terminales del rectificador y el neutro del transformador; realizar una comparación angular entre los vectores de tensión correspondientes a ambas señales de tensión; y determinar si existe una falta en función de un umbral preestablecido.
Patent AU-2001244990-B2 (AU)
Title: Sanitary napkin
Inventor: DREVIK SOLGUN
IPC: A61L15/28
Filed: 2001-04-03
Granted: 2005-07-14
Abstract: An absorbent article aritcle for women includes an absorbent body which is sandwiched between a liquid-permeable outer sheet and a liquid-impermeable outer sheet. The article has a front part, which is intended to face forwards when the article is worn, and a rear part. The absorbent body has a length of 140-260 mm and tapers rearwardly from a section of greatest width situated in the front part of the article to the end of the rear part of the article. The absorbent body has a widest width of 60-80 mm in its front part, and a smallest width of 5-20 mm in its rear end, and includes a layer of dry-formed cellulose fibers having a density of at least 250 g/dm3 and extending over essentially the whole surface of the absorbent body, out to the front and side edges of the body. of a sanitary napkin, a panty liner or an incontinence protector for women comprising an absorbent body (2) which is sandwiched between a liquid-permeable outer sheet (3) and a liquid-impermeable outer sheet (4), said article having a front part (5), which is intended to face forwards when the article is worn, and a rear part, wherein the absorbent body has a length of 140-260 mm and tapers rearwardly from a section of greatest width situated in the front part of the article to the end of the rear part of said article. According to the invention, the absorbent body (2) has a widest width of 60-80 mm in its front part, and a smallest width of 5-20 mm in its rear end, and includes a layer (13) of dry-formed cellulose fibres having a density of at least 250 g/dm3 and extending over essentially the whole surface of the absorbent body, out to the front and side edges of said body.
Patent AU-2001282123-B2 (AU)
Title: Method for producing ready to use, antigen loaded or unloaded, cryoconserved mature dendritic cells
Inventor: SCHULER-THURNER BEATRICE
IPC: C12N15/09
Filed: 2001-08-24
Granted: 2008-02-28
Abstract: The invention relates to a method for producing ready to use, antigen loaded or unloaded, cryoconserved mature dendritic cells especially for the production of a vaccine containing said dendritic cells, wherein immature dendritic cells are cultivated in the presence of suitable maturation stimuli and the mature dendritic cells thus obtained are frozen. The dendritic cells can be loaded with antigen before freezing. The invention also relates to a vaccine which can be obtained according to the inventive method and to a composition containing frozen, mature dendritic cells which are loaded with antigen.
Patent AU-2001286530-B2 (AU)
Title: Oral fast-melt formulation of a cyclooxygenase-2 inhibitor
Inventor: LE TRANG T
IPC: A61K47/26
Filed: 2001-08-17
Granted: 2007-01-25
Abstract: A process is provided for preparing an oral fast-melt composition of a selective cyclooxygenase-2 inhibitory drug comprising (a) a step of wet granulating the selective cyclooxygenase-2 inhibitory drug together with a binding agent selected from gums, polypeptides, natural and modified starches, cellulosic materials, alginic acid and salts thereof, polyethylene glycol, polyvinylpyrrolidone, polymethacrylates, silicate salts and bentonites, and (b) a step of blending with the drug a saccharide of low moldability, wherein the above steps (a) and (b) occur in any order or simultaneously to result in formation of granules. Optionally the process further comprises (c) a step of blending the granules with at least one of a lubricant, a sweetening agent and a flavoring agent to form a tableting blend, and (d) a step of compressing the tableting blend to form oral fast-melt tablets. Also provided is a composition prepared by such a process.
Patent AU-2002218569-B2 (AU)
Title: Complementing cell lines
Inventor: VOGELS RONALD
IPC: C12N5/08
Filed: 2001-11-14
Granted: 2007-04-05
Abstract: A packaging cell line that complements recombinant adenoviruses based on serotypes from subgroup B, preferably adenovirus type 35. The cell line may be derived from primary, diploid human cells that are transformed by adenovirus E1 sequences either operatively linked on one DNA molecule or located on two separate DNA molecules, the sequences being operatively linked to regulatory sequences enabling transcription and translation of encoded proteins. Also disclosed is a cell line derived from PER.C6® that expresses functional Ad35 E1B sequences. The Ad35-E1B sequences are driven by the E1B promoter or a heterologous promoter and terminated by a heterologous poly-adenylation signal. The cell lines are useful for producing recombinant adenoviruses designed for gene therapy and vaccination, and can also be used for producing human recombinant therapeutic proteins such as human growth factors and human antibodies. Also, the cell lines are useful for producing human viruses other than adenovirus such as influenza virus, herpes simplex virus, rotavirus, and measles virus.
Patent AU-2002353718-B2 (AU)
Title: Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
Inventor: BARF TJEERD
IPC: C07D417/12
Filed: 2002-11-22
Granted: 2007-05-10
Abstract: The present invention relates to compounds with the formula (I), and also to pharmaceutical compositions comprising the compounds, as well as to the use of the compounds in medicine and for the preparation of a medicament which acts on the human 11-b-hydroxysteroid dehydrogenase type 1 enzyme.
Patent AU-2003218772-B2 (AU)
Title: Constructs and methods for the regulation of gene expression
Inventor: BAUER JORG
IPC: C12N15/82
Filed: 2003-03-17
Granted: 2008-12-04
Abstract: The present invention relates to constructs and methods for regulating the gene expression of at least two endogenous target genes by introducing, into a eukaryotic cell or a eukaryotic organism, an at least partially double-stranded ribonucleic acid molecule, the ribonucleic acid molecule comprising at least two ribonucleotide sequence segments which are homologous to various genes of the eukaryotic cell.
Patent AU-2003229491-B2 (AU)
Title: Method and device for the generation of checkable forgery-proof documents
Inventor: MEYER BERND
IPC: G06F21/64
Filed: 2003-03-10
Granted: 2008-04-10
Abstract: The invention relates to a method and a device for the generation of checkable forgery-proof documents with an externally supplied cryptographic module, whereby the checking of authenticity of the document is carried out without using key information belonging to the cryptographic module. According to the invention, the method and the device are characterised in that the cryptographic module is supplied with two types of data, even on supply from a communication partner which is cryptographically not trustworthy, which either remain in the cryptographic module or are attached to the document. The information remaining in the cryptographic module is used to secure the document information by means of a check value and the information transferred into the document serves to verify the securing of the document by the cryptographic module during a check of the authenticity of the document at a checkpoint.
Patent AU-2003245962-B2 (AU)
Title: Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hPPAR activators
Inventor: GOSMINI ROMAIN LUC MARIE
IPC: A61K31/19
Filed: 2003-06-18
Granted: 2008-07-03
Abstract: A compound of formula (I) or a pharmaceutically acceptable salt, solvate, or hydrolysable ester thereof, wherein:
Patent AU-2003295471-B2 (AU)
Title: Human monoclonal antibodies against CD25
Inventor: GERARDA HAVENITH CATHARINA EMANUELE
IPC: G01N33/68
Filed: 2003-11-14
Granted: 2011-08-25
Abstract: Isolated human monoclonal antibodies which bind to and inhibit human CD25, and related antibody-based compositions and molecules, are disclosed. The human antibodies can be produced by a hybridoma, a transfectoma or in a nonhuman transgenic animal, e.g., a transgenic mouse, capable of producing multiple isotypes of human monoclonal antibodies by undergoing V-D-J recombination and isotype switching. Also disclosed are pharmaceutical compositions comprising the human antibodies, nonhuman transgenic animals, hybridomas and transfectomas which produce the human antibodies, and therapeutic and diagnostic methods for using the human antibodies.
Patent AU-2004306122-B2 (AU)
Title: A matched filter for scalable spread spectrum communications systems
Inventor: DOBSON KURT W
IPC: H04B/
Filed: 2004-09-24
Granted: 2010-01-28
Abstract: A spread spectrum communications system using long, scalable PN sequences to achieve variable communication rates using a low-complexity and scalable matched filter architecture to provide a large processing gain, robust recovery of multiple devices in long reach, high ambient-noise environments.
Patent AU-2005229358-B2 (AU)
Title: Method and system for determining the position of an object moving along a course
Inventor: ROUSSEAU MICHEL
IPC: B61L25/02
Filed: 2005-03-03
Granted: 2010-12-02
Abstract: The position of an object moving along a course is determined by a relative measured position while its associated second confidence interval is smaller than a first confidence interval associated with an absolute measured position and is determined by the absolute position when the second confidence interval exceeds the first confidence interval.
Patent AU-2005234616-B2 (AU)
Title: Method for caulking the deck of ships
Inventor: ABEE MARCEL L
IPC: F16J15/14
Filed: 2005-11-15
Granted: 2011-02-10
Abstract: Process for caulking a ship deck, which comprises :  a) bonding planks of tropical wood on the subdeck of said ship,  b) sealing said planks through the application of a moisture curable sealing composition, then  c) allowing said composition to cure during an effective period of time, characterized in that said moisture curable sealing composition comprises one or more silyl-modified polyacrylate(s).
Patent AU-2005240023-B2 (AU)
Title: Surgical instrument aspiration valve
Inventor: SJOSTROM DOUGLAS D
IPC: A61B17/32
Filed: 2005-04-18
Granted: 2011-11-10
Abstract: A surgical instrument includes a movable member having a proximal portion, the movable member defining an opening at the proximal portion. The instrument includes a stationary member defining an aperture. The stationary member is arranged relative to the movable member with a close fit between the stationary member and the movable member such that aspiration occurs through the movable member substantially only during a portion of a repetitive motion of the movable member. The instrument includes a surgical handpiece coupled to the movable member and the stationary member to provide suction and motion to the movable member. A method of regulating aspiration through a surgical instrument includes providing a close fit between a moving member having an opening at a proximal portion and a stationary member having an aperture such that aspiration occurs through the moving member substantially only during a portion of a repetitive motion of the movable member. The moving member and the stationary member are coupled to a surgical handpiece to provide suction and motion to the moving member.
Patent AU-2006201653-B2 (AU)
Title: Method and detection system for monitoring the speed of a lift cage
Inventor: LATORRE MARCUZ CARLOS
IPC: B66B5/06
Filed: 2006-04-20
Granted: 2011-06-23
Abstract: Abstract: In this method the speed of a lift cage is monitored. In the case of excess speed caused by brake failure of the motor brake or shaft fracture of the drive pulley shaft the safety circuit is opened and the detection system is transferred from the normal operational state (circle with a 1) to the retardation state (circle with a 2) in which it is monitored whether the lift cage is retarded after defined speed presets. After a successful retardation the detection system is transferred to the state of standstill monitoring (circle with a 3) in which it is monitored whether the lift cage leaves its standstill position. If the presets of state 2 or state 3 are not fulfilled, the detection system is transferred to the braking state of the brake (circle with a 4) in which a brake which fixes the lift cage is activated. (Fig. 2) FIG. 2 vG 3R SCDC 'SCDO abs(vel)<Vstand-still stand still tolerance ORA EXC vos v OR vel-decel -- - --- - -- ---- -- -- -- -- -- -- -- -- vos -- - - - -- -- --- -- --- -- -- -- -- -- -- -- -- -vknm--;- -- -- - ------ -- - -- -- -- -- -- -- -- -- - vel-decel/2 -- --- ---- -- -- ---- - -- -- -- -- -- -- -- vsta d~sill-- -- ---- --- --- --- ------------- ti t t3
Patent AU-2006212037-B2 (AU)
Title: Lighting system
Inventor: LIDDLE RICHARD
IPC: F21V23/06
Filed: 2006-02-07
Granted: 2011-05-26
Abstract: A lighting element (1) comprises at least one light (3), means (13) for delivering electricity to the or each light, a pair of spaced apart plates (2,2′), at least one magnet (4,4′) located between the said plates and biasing means (8) for biasing the said plates apart, wherein a magnet (4) is attached to one of the pair of plates. In use the lighting element forms part of a lighting system in which the element is located between spaced apart transparent sheets (10), e.g. panes of glass.
Patent AU-2006218877-B2 (AU)
Title: Conformable prostheses for implanting two piece heart valves
Inventor: DREWS MICHAEL J
IPC: A61F2/24
Filed: 2006-02-24
Granted: 2012-03-29
Abstract: A heart valve assembly (10) includes an annular prosthesis (14) and a valve prosthesis (14). The annular prosthesis includes an annular ring (18) for dilating tissue within a biological annulus and a conformable sewing cuff (20) extending radially from the annular member. The valve prosthesis includes a frame (32) and a valve component. The annular ring is introduced into the biological annulus to dilate tissue surrounding the biological annulus and the sewing cuff conforms to tissue above the biological annulus. Fasteners are directed through the sewing cuff to secure the annular prosthesis to the biological annulus. The annular prosthesis may include a baleen element for biasing fabric on the annular ring outwardly to enhance sealing against the biological annulus. A valve prosthesis is then advanced into the sinus cavity, and secured relative to the annular prosthesis. The sewing cuff may enhance a seal between the valve prosthesis and annular prosthesis.
Patent AU-2006271325-B2 (AU)
Title: Virtual reality smoking system
Inventor: SUNDAR RANGARAJ S
IPC: A24F42/60
Filed: 2006-05-30
Granted: 2011-09-22
Abstract: A virtual or augmented reality smoking system (200) is provided herein. A smoker using the system can experience a virtual reality of smoking by puffing on a cigarette shaped article (300) and experiencing the taste or aroma from the article while simultaneously viewing a generated image of a burning cigarette and exhaled and sidestream smoke. Additionally, the room environment may be simulated to give the experience of smoking in a setting of the smoker' s choice (virtual reality) or the image of a burning cigarette and smoke may be superimposed on a live or natural image of the smoker's environment (augmented reality).
Patent AU-2006272343-B2 (AU)
Title: Stabilized chlorite solutions in combination with fluoropyrimidines for cancer treatment.
Inventor: GIESE THOMAS
IPC: A61P35/00
Filed: 2006-07-21
Granted: 2012-09-13
Abstract: Pharmaceutical compositions for treating neoplastic disorders and uses thereof are provided. Said pharmaceutical compositions comprise stabilized chlorite solutions (e.g. WFlO) and a fluoropyrimidine, 5 -FU, or a 5-FU prodrug (e.g. capecitabine, doxifluridine, UFT, S-1, or BOF-A2). The use of the above stabilized chlorite solution in combination with a fluoropyrimidine dramatically improves the quality of life index (QOL) of a patient undergoing cancer chemotherapy. Cancers that can be treated include cancers of the pancreas, gastrointestinal, head, neck, and breast.
Patent AU-2007201310-B2 (AU)
Title: Method and apparatus for the manufacture of conduit with assembled components and conduit assembly made therefrom
Inventor: CAMPAU DANIEL N
IPC: B65H51/18
Filed: 2007-03-27
Granted: 2012-04-26
Abstract: METHOD AND APPARATUS FOR THE MANUFACTURE OF CONDUIT WITH ASSEMBLED COMPONENTS AND CONDUIT ASSEMBLY MADE A method and apparatus for performing a manufacturing operation at a plurality of locations along the length of a flexible conduit (12) results in a prefabricated conduit assembly having integrally joined fittings or other manufactured components. The apparatus comprises a driving mechanism (11), a manufacturing station (25), and a support device (17). The conduit is first fed through the manufacturing station and may move either continuously or intermittently. The manufacturing station then performs the manufacturing operation at a plurality of locations along the length of the conduit. The support device within the conduit provides structural support at the manufacturing station during the manufacturing operation and remains at a generally fixed axial and functional location while the conduit continues to move axially. A prefabricated conduit assembly having an elongated conduit body and a plurality of fittings or other manufactured components spaced along the length of the conduit body is useful for simplified installation in single point battery watering systems or other fluid distribution systems. 14 1/3 28{ Fig. 1 10- Fig. 5 20- - - 25 17-1 24 -- - C--------------i 12 k 22 \10
Patent AU-2007202060-B2 (AU)
Title: Anti-D monoclonal antibodies
Inventor: BELIARD ROLAN
IPC: A61P15/00
Filed: 2007-05-08
Granted: 2010-10-14
Abstract: Preparation (M1) of monoclonal antibodies (MAb) that activate effector cells expressing Fcgamma RIII (A). Preparation (M1) of monoclonal antibodies (MAb) that activate effector cells expressing Fcgamma RIII (A). Monoclonal antibodies expressed from different clones, derived from selected hybridomas (especially heterohybridomas) or animal or human cells transfected with a vector containing a gene for an antibody, are purified, then incubated with a mixture containing target cells, effector cells expressing (A), and polyvalent immunoglobulin G (IgG). Those MAb that produce significant lysis of target cells (by induction of (A)-type antibody-dependent cellular cytotoxicity (ADCC)) are chosen. Independent claims are also included for the following: (1) MAb produced by (M1), having type-(A) ADCC over 60%, especially 90% of that for reference polyclonal antibodies; (2) any MAb directed against a particular antigen and able to activate effector cells to provide type-(A) ADCC over 60, especially 90% of that for reference polyclonal antibodies; (3) MAb that have, on the glycosylation site at Asn297 of Fcgamma , two-branched glycosylation structures with short arms, low degree of silylation and terminal mannose residues and/or non-intercalating N-acetylglucosamine (GlcNAc); (4) cells that produce MAb; (5) pharmaceutical composition containing MAb; and (6) diagnostic composition containing MAb. ACTIVITY : Antibacterial; antiviral; cytostatic; hemostatic; immunostimulant. MECHANISM OF ACTION : Antibody-dependent cellular cytotoxicity inducer.
Patent AU-2007234485-B2 (AU)
Title: Highly inhibited starch fillers for films and capsules
Inventor: ZHIXIN LI
IPC: A23L29/281
Filed: 2007-11-13
Granted: 2013-05-30
Abstract: Abstract of the Disclosure The invention provides the addition of highly inhibited starch filler to gelatin free films and soft capsules. The addition of the highly inhibited starch filler raises the solid levels during processing without substantially increasing the melt viscosity. 5 The resultant films and capsules are transparent.